|Articles|April 3, 2023
How to Meet the FDA’s Diversity Guidance
Author(s)Science 37
The pending FDA Guidelines is clear—pharma companies must improve diverse representation in clinical trials. In this whitepaper, Science 37 shares tips and strategies on how to achieve diversity in clinical trials.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference?
2
Modernizing Recruitment with Data, HCP Networks, and Last Mile Support
3
Rethinking Site Selection and Oversight Amid Complex Protocols
4
ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
